Collaborative Partnerships

BRI has established close relationships with industry, academia and government. Through collaborations, BRI promotes scientific exchange and creates opportunities for the commercialization of biotechnological discoveries. We will continue the process of exploring collaborative opportunities to enhance our competitiveness and advance the product development pipeline. Some examples of our strategic partners:

  • Govita Tech Limited
  • GSK China
  • Hong Kong Science and Technology Park
  • NanoMab Technology Ltd
  • Novus Life Sciences Limited
  • Roche China
  • Sanofi-Aventis
  • Universitat Politècnica de València

BRI will also continue to take an active role in promoting Hong Kong’s innovative capabilities in biotechnology. We have established service contracts with the following local organizations:

  • Medical Division of Tung Wah Group of Hospitals
  • Nano and Advanced Materials Institute Limited

Furthermore, BRI is committed to educating and training of the next generation of biotechnologists and actively involves in running biotechnology-related academic programs at HKUST. We collaborate with industrial companies to offer project and internship opportunities to the students.